日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma

免疫治疗的病理反应与接受延迟肾切除术治疗转移性肾细胞癌患者的生存率相关

Khandwala, Yash S; Reese, Stephen W; Ucpinar, Burcin A; Knezevic, Andrea; Eismann, Lennert; Wu, Chih-Ying; Mittal, Rohan; Doshi, Sahil; Barbakoff, Daniel; Sanmiguel, Andrea Lopez; Coleman, Jonathan; Dawidek, Mark; Motzer, Robert J; Russo, Paul; Akin, Oguz; Kotecha, Ritesh R; Chen, Ying-Bei; Voss, Martin H; Ari Hakimi, A

Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone

局部治疗后转移性透明细胞肾细胞癌的长期肿瘤学预后

Barbakoff, Daniel; Dawidek, Mark T; Knezevic, Andrea; Ganz, Marc; Posada, Lina; Khandwala, Yash; Sanmiguel, Andrea Lopez; Reese, Stephen W; Oparanozie, Arnold; Liso, Nicole; Kotecha, Ritesh R; Motzer, Robert J; Reznik, Ed; Coleman, Jonathan; Ostrovnaya, Irina; Voss, Martin H; Russo, Paul; Hakimi, A Ari

Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling.

通过整合基因组和转录组分析鉴定肾髓质癌的治疗靶点。

Msaouel Pavlos, Tannir Nizar M, Meric-Bernstam Funda, King Jennifer M, Voss Martin H, Cheng Jessica P, Thomas Susan S, Lim Zita D, Karki Menuka, He Rong, Genovese Giannicola, Sheth Rahul A, Ingram Davis R, Shamsutdinova Diana, Wani Khalida M, Wang Wei-Lien, Lazar Alexander J, Knipper-Davis Dominique, Berlinski Amber, Soares Tayla, Stupichev Danil, Kryukov Kirill, Davitavyan Suren, Novokreshchenova Anna, Lebedev Dmitry, Kurpe Stanislav, Kravets Andrey, Belousov Dmitrii, Hensley Michael, Bagaev Alexander, Paradiso Francesca, Kushnarev Vladimir

Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery

立体定向放射外科治疗肾细胞癌脑转移的临床结果和靶向基因组分析

Ma, Jennifer; Del Balzo, Luke; Walch, Henry; Khaleel, Sari; Knezevic, Andrea; Flynn, Jessica; Zhang, Zhigang; Eichholz, Jordan; Doshi, Sahil D; Voss, Martin H; Freeman, Benjamin; Ari Hakimi, A; Lee, Chung-Han; Bale, Tejus A; Kelly, Daniel; Mueller, Boris A; Mann, Justin; Yu, Yao; Zinovoy, Melissa; Chen, Linda; Cuaron, John; Khan, Atif; Yamada, Yoshiya; Shin, Jacob Y; Beal, Kathryn; Moss, Nelson S; Carlo, Maria I; Motzer, Robert J; Imber, Brandon S; Kotecha, Ritesh R; Pike, Luke R G

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

一项针对晚期透明细胞肾细胞癌的 1b/2 期研究,评估巴替拉西普单药治疗以及联合卡博替尼(加或不加纳武利尤单抗)治疗晚期透明细胞肾细胞癌的疗效。

Beckermann, Kathryn E; Shah, Neil J; Campbell, Matthew T; Haas, Naomi B; Nelson, Ariel; Ornstein, Moshe C; Mao, Shifeng; Keshava-Prasad, Holavanahalli S; Hammers, Hans; Gao, Xin; Gourdin, Theodore; George, Saby; Hoimes, Christopher J; Hussain, Arif; Jonasch, Eric; Rini, Brian I; Voss, Martin H

Prospective Study of Patient, Nursing, and Oncology Provider Perspectives on Telemedicine Visits for Renal Cell Carcinoma Clinical Trials

肾细胞癌临床试验中患者、护理人员和肿瘤科医生对远程医疗就诊的看法的前瞻性研究

Doshi, Sahil D; Knezevic, Andrea; Gonzalez, Carlene; Fischer, Patricia; Goodman, Robert; Gornell, Suzanne; Patel, Sweta; Puzio, Cindy; Ritea, Alisa; Lee, Chung-Han; Evans, Lauren; Voss, Martin H; Motzer, Robert J; Kotecha, Ritesh R

Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma

免疫治疗的病理反应与接受延迟肾切除术治疗转移性肾细胞癌患者的生存率相关

Khandwala, Yash S; Reese, Stephen W; Ucpinar, Burcin A; Knezevic, Andrea; Eismann, Lennert; Wu, Chih-Ying; Mittal, Rohan; Doshi, Sahil; Barbakoff, Daniel; Sanmiguel, Andrea Lopez; Coleman, Jonathan; Dawidek, Mark; Motzer, Robert J; Russo, Paul; Akin, Oguz; Kotecha, Ritesh R; Chen, Yingbei; Voss, Martin H; Hakimi, A Ari

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214

接受纳武利尤单抗联合伊匹木单抗治疗与舒尼替尼治疗的晚期肾细胞癌患者的无治疗生存期和分区生存期分析:CheckMate 214 研究的 5 年更新

Mantia, Charlene M; Jegede, Opeyemi A; Plimack, Elizabeth R; Powles, Thomas; Motzer, Robert J; Tannir, Nizar M; Lee, Chung-Han; Tomita, Yoshihiko; Voss, Martin H; Choueiri, Toni K; Rini, Brian I; Hammers, Hans J; Escudier, Bernard; Albigès, Laurence; Rosenblatt, Lisa; Atkins, Michael B; Regan, Meredith M; McDermott, David F

A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer

一项针对基因组定义的转移性肾癌的Talazoparib联合Avelumab的II期临床试验

Kotecha, Ritesh R; Doshi, Sahil D; Knezevic, Andrea; Chaim, Joshua; Chen, Yingbei; Jacobi, Rachel; Zucker, Mark; Reznik, Ed; McHugh, Deaglan; Shah, Neil J; Feld, Emily; Aggen, David H; Rafelson, William; Xiao, Han; Carlo, Maria I; Feldman, Darren R; Lee, Chung-Han; Motzer, Robert J; Voss, Martin H

Genomic ancestry in kidney cancer: Correlations with clinical and molecular features

肾癌的基因组祖先:与临床和分子特征的相关性

Kotecha, Ritesh R; Knezevic, Andrea; Arora, Kanika; Bandlamudi, Chaitanya; Kuo, Fengshen; Carlo, Maria I; Fitzgerald, Kelly N; Feldman, Darren R; Shah, Neil J; Reznik, Ed; Hakimi, A Ari; Carrot-Zhang, Jian; Mandelker, Diana; Berger, Michael; Lee, Chung-Han; Motzer, Robert J; Voss, Martin H